Paysign raises FY25 revenue view to $72M-$74M from $68.5M-$70M

Consensus $69.41M. “With the results of our first quarter of 2025 now in the books and our preliminary purchase price allocation for the Gamma acquisition now substantially complete, we are revising our full-year 2025 estimated results upward. We expect total revenues to be in the range of $72.0 million to $74.0 million, reflecting year-over-year growth of 25.0% at the midpoint. Plasma is estimated to make up approximately 57% of total revenue, representing a year-over-year decline of 8.0% to 10.0%, while patient affordability revenue is expected to make up approximately 43.0% of total revenue, representing year-over-year growth of over 135%. Given the seasonality we see with our patient affordability business and trends in our plasma business, we continue to forecast revenue to be slightly higher in the first half of the year compared to the second half of the year with a corresponding impact on operating income. Full-year gross profit margins are expected to be between 62.0% and 64.0% reflecting stable margins in our plasma business and increased revenue contribution from our pharma patient affordability business. Operating expenses are being revised lower due to operational synergies driven by the Gamma acquisition as well as revisions to stock compensation and amortization following the purchase price allocation for Gamma. Operating expenses are now expected to be between $41.0 million and $43.0 million with depreciation and amortization expense of approximately $8.0 million and stock-based compensation of approximately $3.8 million. Interest income is estimated to be approximately $2.9 million. Taking all the factors above into consideration, we now expect net income to be between $6.0 million and $7.0 million for the year, or $0.10 to $0.12 per diluted share. Adjusted EBITDA is expected to be in the range of $16.0 million to $17.0 million, or $0.28 to $0.30 per diluted share. The diluted share count for the year is estimated to be 56.0 million shares.”